COMPARATIVE EFFICACY AND SAFETY OF TOFACITINIB AND BIOLOGICS AS INDUCTION THERAPY FOR MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
|
作者：
Rubin, D. T. [1 ]
Ashaye, A. O. [2 ]
Zhang, Y. [3 ]
Xu, Y. [2 ]
Fahrbach, K. [2 ]
Chen, L. A. [4 ]
Manuchehri, A. [5 ]
Kayhan, C. [6 ]
Woolcott, J. C. [7 ]
Cappelleri, J. C. [8 ]
Healey, P. [8 ]
机构：
[1] Univ Chicago Med, Chicago, IL USA
[2] Evidera Inc, Waltham, MA USA
[3] Evidera, London, England
[4] NYU Langone Med Ctr, New York, NY USA
[5] Pfizer Ltd, Tadworth, England
[6] Pfizer Inc, Collegeville, PA USA
[7] Pfizer Canada Inc, Kirkland, PQ, Canada
[8] Pfizer Inc, Groton, CT 06340 USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PGI4
引用
收藏
页码：A180 / A180
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of tofacitinib in the treatment of patients with active, moderate to severe, Ulcerative Colitis: a systematic review and meta-analysis
    Khorshid, M.
    Dorgham, D.
    Sharobim, A.
    Attia, M.
    Hussein, M.
    Dorgham, N.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S446 - S447
  • [22] Comparative Efficacy and Safety of Upadacitinib Versus Tofacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: A Matching-Adjusted Indirect Comparison
    Reinisch, W.
    Tran, J.
    Patel, K.
    Borruel, N.
    Melmed, G. Y.
    Wegrzyn, L.
    Levy, G.
    Ilo, D.
    Gonzalez, Y. Sanchez
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 785 - 786
  • [23] Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
    Paschos, P.
    Katsoula, A.
    Giouleme, O.
    Tsapas, A.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S418 - S419
  • [24] Tofacitinib Has Induction Efficacy in Moderately to Severely Active Ulcerative Colitis, Regardless of Prior TNF Inhibitor Therapy
    Sands, Bruce
    D'Haens, Geert
    Sandborn, William J.
    Hibi, Toshifumi
    Su, Chinyu
    Niezychowski, Wojciech
    Ghosh, Subrata
    Zhang, Haiying
    Yu, Dahong
    Woodworth, Deborah
    Healey, Paul
    Marren, Amy
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S261 - S261
  • [25] Effectiveness and Safety of Tofacitinib for Ulcerative Colitis Systematic Review and Meta-analysis
    Taneja, Vikas
    El-Dallal, Mohammed
    Haq, Zadid
    Tripathi, Kartikeya
    Systrom, Hannah K.
    Wang, Linda F.
    Said, Hyder
    Bain, Paul A.
    Zhou, Youlian
    Feuerstein, Joseph D.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (10) : E323 - E333
  • [26] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Xinqiao Chu
    Yaning Biao
    Chengjiang Liu
    Yixin Zhang
    Chenxu Liu
    Ji-zheng Ma
    Yufeng Guo
    Yaru Gu
    BMC Gastroenterology, 23
  • [27] Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis
    Chu, Xinqiao
    Biao, Yaning
    Liu, Chengjiang
    Zhang, Yixin
    Liu, Chenxu
    Ma, Ji-Zheng
    Guo, Yufeng
    Gu, Yaru
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [28] REAL-WORLD EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS: SYSTEMATIC REVIEW AND META-ANALYSIS
    Taneja, Vikas
    El-Dallal, Mohammed
    Haq, Zadid
    Tripathi, Kartikeya
    Wang, Linda F.
    Systrom, Hannah
    Said, Hyder
    Zhou, Youlian
    Feuerstein, Joseph D.
    GASTROENTEROLOGY, 2021, 160 (06) : S344 - S344
  • [29] Efficacy and Safety of Tofacitinib in Moderate-Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis
    Dhindsa, Banreet
    Dhaliwal, Amaninder
    Mashiana, Harmeet
    Choa, Jacqueline
    Sayles, Harlan
    Ohning, Gordon
    Hewlett, Alexander
    Young, Renee
    Eichele, Derrick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S478 - S478
  • [30] Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation (vol 6, e000302, 2019)
    Lohan, C.
    Diamantopoulos, A.
    LeReun, C.
    BMJ OPEN GASTROENTEROLOGY, 2020, 7 (01):
12345